4//SEC Filing
DAmour Kevin 4
Accession 0001140361-22-024524
CIK 0000748592other
Filed
Jun 28, 8:00 PM ET
Accepted
Jun 29, 8:01 PM ET
Size
8.3 KB
Accession
0001140361-22-024524
Insider Transaction Report
Form 4
DAmour Kevin
See Remarks
Transactions
- Tax Payment
Common Stock
2022-06-28$0.55/sh−6,077$3,363→ 11,496 total - Exercise/Conversion
Restricted Stock Units
2022-06-28−17,573→ 52,717 total→ Common Stock (17,573 underlying) - Exercise/Conversion
Common Stock
2022-06-28+17,573→ 17,573 total
Footnotes (2)
- [F1]Each restricted stock unit converts into one share of common stock.
- [F2]On June 28, 2021, the reporting person was granted 70,290 restricted stock units, vesting in four substantially equal installments beginning on the first anniversary of the grant date.
Documents
Issuer
Brooklyn ImmunoTherapeutics, Inc.
CIK 0000748592
Entity typeother
Related Parties
1- filerCIK 0001870486
Filing Metadata
- Form type
- 4
- Filed
- Jun 28, 8:00 PM ET
- Accepted
- Jun 29, 8:01 PM ET
- Size
- 8.3 KB